These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15490946)

  • 1. [Serotonin metabolism dysfunction in pathogenesis of nervous system disorders].
    Izzati-zade KF; Basha AV; Demchuk ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(9):62-70. PubMed ID: 15490946
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin in the pathophysiology and treatment of CNS disorders.
    Di Giovanni G
    Exp Brain Res; 2013 Oct; 230(4):371-3. PubMed ID: 24057054
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serotonin and neurologic disorders].
    Hyyppä MT
    Duodecim; 1976; 92(21):1206-16. PubMed ID: 991774
    [No Abstract]   [Full Text] [Related]  

  • 4. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.
    De Keyser J; Mostert JP; Koch MW
    J Neurol Sci; 2008 Apr; 267(1-2):3-16. PubMed ID: 17935736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of studying biologically active substances in various diseases of the nervous system].
    Makarov AIu; Goncharova VA; Sachkova LA
    Vopr Psikhiatr Nevropatol; 1968; 13():542-8. PubMed ID: 5741041
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of central serotonin nerve lesions on blood pressure in normotensive and hypertensive rats.
    Howe PR; Stead BH; Lovenberg W; Chalmers JP
    Clin Exp Pharmacol Physiol; 1982; 9(3):335-9. PubMed ID: 7140014
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of platelet activating factor (PAF) in physiology and pathology of the central nervous system].
    Farbiszewski R; Dudek H; Skrzydlewska E; Lewko J
    Neurol Neurochir Pol; 2002; 36(4):801-8. PubMed ID: 12418143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional channelopathies: an emerging class of disorders.
    Waxman SG
    Nat Rev Neurosci; 2001 Sep; 2(9):652-9. PubMed ID: 11533733
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of brain and skeletal muscle energy metabolism in multiple system atrophy shown by in vivo phosphorous MR spectroscopy.
    Martinelli P; Giuliani S; Lodi R; Iotti S; Zaniol P; Barbiroli B
    Adv Neurol; 1996; 69():271-7. PubMed ID: 8615139
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional disturbances during slow viral infections of the central nervous system.
    Kristensson K
    Ann N Y Acad Sci; 1994 Jun; 724():14-21. PubMed ID: 8030933
    [No Abstract]   [Full Text] [Related]  

  • 11. The gut microbiota and its correlations with the central nervous system disorders.
    Catanzaro R; Anzalone M; Calabrese F; Milazzo M; Capuana M; Italia A; Occhipinti S; Marotta F
    Panminerva Med; 2015 Sep; 57(3):127-43. PubMed ID: 25390799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of P32 for clinical studies of the permeability of the blood-brain barrier].
    Leksin EN
    Med Radiol (Mosk); 1967 May; 12(5):47-50. PubMed ID: 5621326
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of serotonin in the enhancement of the rat spinal excitability by high pressures.
    David JM; Risso JJ; Pellet J
    Undersea Biomed Res; 1988 Jan; 15(1):1-11. PubMed ID: 3368990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular space diffusion and pathological states.
    Syková E; Mazel T; Vargová L; Vorísek I; Prokopová-Kubinová S
    Prog Brain Res; 2000; 125():155-78. PubMed ID: 11098655
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurodisability and the channelopathies.
    Zuberi S
    Dev Med Child Neurol Suppl; 2003 Aug; 95():12-3. PubMed ID: 12898984
    [No Abstract]   [Full Text] [Related]  

  • 16. [To promote the repairment of CNS by targeting PTen].
    Yang P
    Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):313-6. PubMed ID: 21416954
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxygen radicals and other toxic oxygen metabolites as key mediators of the central nervous system tissue injury.
    Marzatico F; Cafè C
    Funct Neurol; 1993; 8(1):51-66. PubMed ID: 8330754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of zinc in the pathogenesis and treatment of central nervous system (CNS) diseases. Implications of zinc homeostasis for proper CNS function.
    Tyszka-Czochara M; Grzywacz A; Gdula-Argasińska J; Librowski T; Wiliński B; Opoka W
    Acta Pol Pharm; 2014; 71(3):369-77. PubMed ID: 25265815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic dysfunction in central nervous system disorders.
    Aminoff MJ
    Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):482-6. PubMed ID: 1515688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of the central nervous system.
    Shellenberger MK; Walaszek E
    Prog Neurol Psychiatry; 1970; 25():106-29. PubMed ID: 4395104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.